The International Comprehensive Epilepsy Center at University of Miami Hospital has been designated as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers. The designation is the highest level awarded by the association, which evaluates the quality of specialized epilepsy care in the United States.
A team of Miller School researchers has found a strong correlation between the type of aortic valve replacement procedure a patient undergoes and the development of post-operative atrial fibrillation. Their findings are reported in an article, “New-Onset Atrial Fibrillation After Aortic Valve Replacement,” that appears in the April 22 issue of the Journal of the American College of Cardiology.
Alan S. Livingstone, M.D., the Lucille and DeWitt Daughtry Professor and Chairman of Surgery, is usually addressed as “Dr. Livingstone,” sometimes as “Professor Livingstone.” Now there is a new option: “Your Excellency.” On March 27, Livingstone was inducted into Brazil’s National Academy of Medicine, one of the oldest and most exclusive medical academies in the world, and the title accompanies that honor.
A group of Miller School scientists has received a $1.6 million small business award from the National Institute of Neurological Disorders and Stroke, a unit of the National Institutes of Health, to support development and clinical trials of a novel anti-inflammatory antibody treatment for human spinal cord injury.
The Miller School’s Department of Neurology is one of three institutions selected to participate in a collaborative research program to develop groundbreaking new methods of preventing, diagnosing and treating stroke, the second-leading cause of death worldwide. Funding began this month, and the department will receive $2.4 million over four years.
